Q2 FY18 Consolidated operating income at Rs 5,592 mn (y-o-y of 14.7%) with EBITDA of Rs 638 mn

Bengaluru, India, November 7th, 2017 – Narayana Hrudayalaya Limited, a leading healthcare service provider in India, today announced its financial results for the second quarter (Q2 FY18) and six months (H1 FY18) ended September 30th, 2017. Financial Highlights for the Quarter (Q2 FY18) - Prepared in accordance with Ind AS (‘Indian Accounting Standards’)

▪ Consolidatedtotal operating income was Rs 5,592 mn for Q2 FY18 as compared to Rs 4,874 mnin the corresponding period of the previous year, reflecting an increase of14.7%

▪ ConsolidatedEBITDA stood at Rs 638 mn, reflecting a margin of 11.4% as against Rs 681 mn inQ2 FY17

▪ PAT afterminority interest and share of loss in associates stood at Rs 165 mn ascompared to Rs 265 mn in Q2 FY17


Financial Highlights for the Six Months (H1 FY18)


▪ Consolidatedtotal operating income was Rs 10,803 mn for H1 FY18 as compared to Rs 9,394 mnin the corresponding period of the previous year, reflecting an increase of15.0%

▪ ConsolidatedEBITDA stood at Rs 1,194 mn, reflecting a margin of 11.1% as against Rs 1,240mn in H1 FY17

▪ PAT afterminority interest and share of loss in associates stood at Rs 275 mn ascompared to Rs 437 mn in H1 FY17


As on September30th, 2017, the consolidated net debt was Rs 3,375 mn representing a net debt toequity ratio of 0.34


Other Highlights during the Quarter


▪ Oursuperspeciality hospital at Vaishno Devi, Jammu performed its 5,000th dialysisin August 2017 (17th month of operations) cementing the facility’s pre-eminencein nephrology in the northern region of the country

▪ Our hospitalin Mumbai successfully performed Extracorporeal Membrane Oxygenation (ECMO) ona little girl suffering from H1N1 and severe hypoxemic respiratory failure, theprocedure being first of its kind in a paediatric case in Mumbai

▪ For the firsttime in Eastern India, a patient was successfully treated with FlatteringFilter-Free Radiotherapy in Narayana Superspeciality Hospital, Howrahbolstering our reputation as a leading player in oncology

▪ Our hospitalin Howrah successfully performed a complicated procedure involvingIntra-Cardiac Repair for Tetralogy of Fallot along with a complete chest wallreconstruction on a 2-year-old girl

▪ NH won TheEconomic Times “The Best Asian Healthcare Brands 2017” award and “The ExpressHealthcare Excellence Award 2017” in Health Tourism category in September 2017

▪ Our SRCCChildren’s Hospital won “The Best Emerging Brand” award at the National Awardfor Marketing Excellence presented by Times Network in September 2017


Management Comment


Commenting on theperformance, Dr. Ashutosh Raghuvanshi, Vice Chairman, Managing Director andGroup CEO, Narayana Hrudayalaya Limited, said “First quarter of fiscal 2018,despite being hit by regulatory challenges, witnessed a strong growth in revenuesand we are pleased to report that the second quarter continued with the strongmomentum generated in Q1 FY18. Results in this quarter are in accordance withour expectations taking into consideration the typical maturity cycle a newlycommissioned hospital like our Mumbai facility experiences in its initial phaseof operations. We remain confident about the long-term prospects of ourbusiness and committed towards the growth trajectory NH has charted upon.” 

  (0)   Comment